News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
MSK received top rankings in gynecology, urology, and several subspecialties
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
This new era of cancer research investigates how the disease in certain locations interacts with all the body’s systems. Focusing on cancer’s ecosystem promises to reveal lifesaving insights, especially into metastasis.
Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
To help Bridget Anderson overcome leukemia, MSK doctors called upon her own microbiome, the vast ecosystem of microorganisms that live within us, especially the gut. They’re both friend and foe in fighting cancer.
Stay Connected with MSK
News Releases
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.
The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering.
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.
Media Coverage
New Yorkers got together this weekend at Wollamn Rink in Central Park to beat rare cancer with Cycle for Survival. Teams of riders led by Equinox instructors participated in the stationary bike event to raise money and bring awareness to the cause. Every dollar donated goes to the research and clinical trials at Memorial Sloan Kettering Cancer Center.
Monday, May 23, 2022
For MSK patient Scott Rosato, preparedness is innate. He is Suffolk County corrections officer and also a lover of the great outdoors, but it’s his vigilance that helps keep him healthy. He’s had close to 20 surgeries now for melanoma, and the battle scars are a reminder of how proactive he’s been. MSK’s Ashfaq Marghoob is quoted.
Wednesday, May 18, 2022
To celebrate National Nurses Week, Today Show anchor, Hoda Kotb, interviewed MSK Kids nurse Cassie DeMatteis and one of our MSK Kids patients, Rocco DiMaggio, and his family. Rocco first met Cassie when he was treated for Stage 4 neuroblastoma at MSK Kids in 2020, and Cassie quickly became Rocco’s favorite nurse. The Today Show interviewed Rocco’s family about their extraordinary relationship with Cassie and Hoda even surprised little Rocco with a reunion with Cassie, who the DiMaggio’s affectionately call Rocco’s “girlfriend”.
Tuesday, May 10, 2022
News from the Lab
Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.
Data from 25,000 patients is helping scientists answer this and many other important questions.
A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.
MSK News
Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Discover how cyclist Stacia Smart turned her grief into purpose after her boyfriend died of a brain tumor.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.
